[go: up one dir, main page]

AU784656B2 - Novel therapeutic use of enoxaparin - Google Patents

Novel therapeutic use of enoxaparin Download PDF

Info

Publication number
AU784656B2
AU784656B2 AU31830/01A AU3183001A AU784656B2 AU 784656 B2 AU784656 B2 AU 784656B2 AU 31830/01 A AU31830/01 A AU 31830/01A AU 3183001 A AU3183001 A AU 3183001A AU 784656 B2 AU784656 B2 AU 784656B2
Authority
AU
Australia
Prior art keywords
enoxaparin
study
treatment
rats
hours
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31830/01A
Other languages
English (en)
Other versions
AU3183001A (en
Inventor
Veronique Mary
Jean-Marie Stutzmann
Andre Uzan
Florence Wahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of AU3183001A publication Critical patent/AU3183001A/en
Application granted granted Critical
Publication of AU784656B2 publication Critical patent/AU784656B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU31830/01A 2000-01-06 2001-01-03 Novel therapeutic use of enoxaparin Ceased AU784656B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0000137A FR2803522B1 (fr) 2000-01-06 2000-01-06 Nouvelle application therapeutique de l'enoxaparine
FR00/00137 2000-01-06
PCT/FR2001/000014 WO2001049298A2 (fr) 2000-01-06 2001-01-03 Nouvelle application therapeutique de l"enoxaparine

Publications (2)

Publication Number Publication Date
AU3183001A AU3183001A (en) 2001-07-16
AU784656B2 true AU784656B2 (en) 2006-05-18

Family

ID=8845669

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31830/01A Ceased AU784656B2 (en) 2000-01-06 2001-01-03 Novel therapeutic use of enoxaparin

Country Status (30)

Country Link
EP (1) EP1248638B1 (fr)
JP (1) JP2003519185A (fr)
KR (1) KR20020069240A (fr)
CN (1) CN1400905A (fr)
AR (1) AR026804A1 (fr)
AT (1) ATE344671T1 (fr)
AU (1) AU784656B2 (fr)
BR (1) BR0107442A (fr)
CA (1) CA2396178A1 (fr)
CZ (1) CZ20022303A3 (fr)
DE (1) DE60124373T2 (fr)
DK (1) DK1248638T3 (fr)
EA (1) EA006035B1 (fr)
EE (1) EE200200374A (fr)
ES (1) ES2275648T3 (fr)
FR (1) FR2803522B1 (fr)
HK (1) HK1052649A1 (fr)
HR (1) HRP20020573A2 (fr)
HU (1) HUP0204040A3 (fr)
IL (1) IL150477A0 (fr)
MX (1) MXPA02006672A (fr)
NO (1) NO20023243D0 (fr)
NZ (1) NZ520283A (fr)
PL (1) PL357192A1 (fr)
PT (1) PT1248638E (fr)
SK (1) SK9612002A3 (fr)
UA (1) UA75587C2 (fr)
WO (1) WO2001049298A2 (fr)
YU (1) YU51802A (fr)
ZA (1) ZA200205415B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2231358C2 (ru) * 2002-06-11 2004-06-27 Научно-исследовательский институт кардиологии Томского научного центра СО РАМН Способ лечения острого коронарного синдрома без подъема сегмента st
CL2007003121A1 (es) * 2006-10-30 2008-05-16 Aventis Pharma Sa Uso de una dosis de 40 mg de enoxaparina sodica como minimo para tratar a un paciente de 65 anos de edad o mayor con ictus isquemico agudo o una puntuacion media de 10 o superior en la escala de nih para el ictus.
ITMI20091445A1 (it) * 2009-08-07 2011-02-08 Inalco S P A A Socio Unico Derivati semi-sintetici del polisaccaride k5 per la prevenzione ed il trattamento del danno tissutale associato a ischemia e/o riperfusione

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5442594A (en) * 1992-10-13 1994-05-09 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PRATT ET AL. (1998), HAEMOSTASIS: 28: 78-85 *

Also Published As

Publication number Publication date
HUP0204040A2 (hu) 2003-04-28
AR026804A1 (es) 2003-02-26
CA2396178A1 (fr) 2001-07-12
ES2275648T3 (es) 2007-06-16
HRP20020573A2 (en) 2003-10-31
WO2001049298A3 (fr) 2002-04-04
EE200200374A (et) 2003-12-15
DK1248638T3 (da) 2007-03-19
CN1400905A (zh) 2003-03-05
BR0107442A (pt) 2002-10-08
MXPA02006672A (es) 2002-09-30
IL150477A0 (en) 2002-12-01
FR2803522B1 (fr) 2004-01-02
EA200200750A1 (ru) 2003-02-27
PT1248638E (pt) 2007-02-28
EP1248638B1 (fr) 2006-11-08
ATE344671T1 (de) 2006-11-15
DE60124373T2 (de) 2007-08-30
FR2803522A1 (fr) 2001-07-13
HUP0204040A3 (en) 2003-05-28
EP1248638A2 (fr) 2002-10-16
NZ520283A (en) 2004-09-24
UA75587C2 (en) 2006-05-15
YU51802A (sh) 2005-06-10
WO2001049298A2 (fr) 2001-07-12
NO20023243L (no) 2002-07-04
EA006035B1 (ru) 2005-08-25
SK9612002A3 (en) 2002-12-03
DE60124373D1 (de) 2006-12-21
CZ20022303A3 (cs) 2002-11-13
JP2003519185A (ja) 2003-06-17
AU3183001A (en) 2001-07-16
KR20020069240A (ko) 2002-08-29
PL357192A1 (en) 2004-07-26
ZA200205415B (en) 2003-10-13
HK1052649A1 (zh) 2003-09-26
NO20023243D0 (no) 2002-07-04

Similar Documents

Publication Publication Date Title
Philipson Pharmacokinetics of antibiotics in pregnancy and labour
MXPA00009159A (es) Formulaciones de dextrano y metodo para el tratamiento de desordenes inflamatorios de articulaciones.
JPH085786B2 (ja) 末梢神経障害の治療処置におけるアセチル−ｌ−カルニチンの使用
EP3305305B1 (fr) Compositions à base de silicate et procédés de traitement
JPH06329541A (ja) 糖尿病性腎症治療用スロデキサイド含有医薬
AU784656B2 (en) Novel therapeutic use of enoxaparin
HUT76895A (en) Use of hyaluronic acid for preparing pharmaceutical compns. for treatment of disease and conditions associated with macrophage infiltration
EP0305181A2 (fr) Ethyl-(+)-apovincaminat pour le traitement des symptômes cliniques de la démyélinisation d'origine autoimmune
US20040214796A1 (en) Novel therapeutic application of enoxaparin
SAKURAI et al. The protective effect of 2-mercapto-ethane sulfonate (MESNA) on hemorrhagic cystitis induced by high-dose ifosfamide treatment tested by a randomized crossover trial
US6579858B1 (en) Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas
JP4073986B2 (ja) 脊髄潅流液
AU2002351915A1 (en) Uso of specific dose of fondaparinux sodium for the treatment of ACS
WO2003041722A1 (fr) Utilisation d'une dose specifique de fondaparinux sodique pour traiter des syndromes coronariens aigus
JP3806945B2 (ja) ヒト由来アンチトロンビン−ｉｉｉの新規用途
JP3381198B2 (ja) １，４−ジヒドロピリジンの糖尿病における使用
WO1995019789A1 (fr) Agent de prevention ou de traitement des troubles moteurs
WO1994004017A2 (fr) Nouveau procede de traitement
EP0633782A1 (fr) Compositions pharmaceutiques contenant des derives de monosialoganglioside pouvant etre utilisees pour traiter des lesions de la moelle epiniere
SILBERT Studies on thrombo-angiitis obliterans (Buerger)
JPS62103019A (ja) 抗めまい剤